Cosette acquires worldwide rights to Endoceutics’ Intraros prescription drug
Pharma Leaders
JUNE 9, 2023
Cosette Pharmaceuticals has acquired the worldwide rights to prescription drug, Intraros, from Endorecherche’s subsidiary Endoceutics. It is expected to be launched in Asian market in 2025. Intrarosa is said to be the only prescription drug that provides estrogen as well as androgen to treat moderate-to-severe dyspareunia.
Let's personalize your content